Akademik Veri Yönetim Sistemi
32nd International Congress of Psychology, 19-24 July, 2020 Prague, Czech Republic, Praha, Çek Cumhuriyeti, 19 - 24 Temmuz 2021, ss.1
Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) patients are similar for the patterns of symptomology and the treatment styles. These diseases have the same etiological explanations. However, it is known that these diseases have differences between using medication code, type, and frequency. On the other hand, medication adherence is the most important part of both of their treatment process to result in their well-being. Both of them are used in NSAII, DMARD and AntiTNF code of medication, also these codes are carried out injection, serum, cream, oral and depot types. Besides, the duration of treatment and diagnosis are determinant in their illness experiences. Therefore, in this study, it is aimed to analyze that the patients’ diagnosis and clinical properties make differentiates or not in medication adherence. The sample of the study consists of 112 RA and 110 AS patients who were treated with medicines. Medication adherence is evaluated in the Medication Adherence Report Scale, and clinical properties (having diagnosis duration, time of treatment, medication code and type) are assessed in Clinical and Sociodemographic Information Form which is organized by researchers. This study was analyzed in Two-Way ANOVA. According to the results of the analysis, the effects of having diagnosis and diagnosis duration [F(4-7.257)= .086, p>,05], the time of treatment [F(4-7.257)= .909, p>,05], the medication type [F(8-7.257)= .880, p>,05] interaction on the medication adherence were not statistically significant. In addition, it was found that the common effect of the medication codes and the which diagnosis they had, were statistically significant [F(4-7.257)= 4,704, p<,05]. In other words, RA patients using NSAII code medication had higher adherence levels, while AS group using DMARD code was found having higher adherence. As a result, NSAII code medication is more usable in the RA, but DMARD is more available in the AS group patients.